Sabra Health Care REIT, Inc.
No enriched coverage for $SBRA in the last 7 days.
MATROS RICHARD K (Chair, CEO and President) sold 200,000 indirectly-held shares of Sabra Health Care REIT, Inc. (SBRA) at $20.83 ($4.17M total) on 2026-09-08 under a Rule 10b5-1 trading plan.
24/7 Wall St. lists Thursday analyst calls. JPMorgan upgraded Charles River Laboratories (CRL) to Overweight, target $310. Wolfe raised Global Payments (GPN) to Outperform, target $110. Argus upgraded Roper Technologies (ROP) to Buy, target $450. Piper cut AppLovin (APP) to Neutral, target $385, and HubSpot (HUBS) to Neutral, target $220. Several other upgrades, downgrades, and initiations are noted.
Sabra Health Care REIT (SBRA) shares rose about 0.2% to around $20.66 after Q2 2026 results. Revenue increased to $238.09 million from $189.98 million, but net income fell to a $25.20 million loss from a $65.54 million profit. Normalized FFO was $0.38 and adjusted FFO $0.40, supporting a $0.30 dividend. The company recorded a $102.4 million loan loss provision.
Recent SBRA coverage spans financial news, earnings and sector analysis.
In the last 30 days, SBRA insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($4.2M). The most active reporter was MATROS RICHARD K, Chair, CEO and President, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Insider sale of $4.2M may signal reduced confidence from top management.
Downgrade-to-neutral style improvement can reduce downside pressure, though lack of target limits conviction.
Cash-flow coverage looks intact, but the large loan-loss provision and ongoing Avamere transition risk keep credit volatility in focus.
The filing updates 2026 outlook and shows Q2 2026 operating drivers (loan-loss reserves, lease termination, and non-cash items) that can shift REIT valuation expectations.
Tenant transition and guidance raise are the most concrete, company-specific catalyst in the piece for SBRA.
AlphAI scores every news story that mentions SBRA with an AI model for sentiment and relevance, and aggregates insider trades from Sabra Health Care REIT, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
MATROS RICHARD K (Chair, CEO and President) sold 200,000 indirectly-held shares of Sabra Health Care REIT, Inc. (SBRA) at $20.83 ($4.17M total) on 2026-09-08 under a Rule 10b5-1 trading plan.
1 min read24/7 Wall St. lists Thursday analyst calls. JPMorgan upgraded Charles River Laboratories (CRL) to Overweight, target $310. Wolfe raised Global Payments (GPN) to Outperform, target $110. Argus upgraded Roper Technologies (ROP) to Buy, target $450. Piper cut AppLovin (APP) to Neutral, target $385, and HubSpot (HUBS) to Neutral, target $220. Several other upgrades, downgrades, and initiations are noted.
4 min readSabra Health Care REIT (SBRA) shares rose about 0.2% to around $20.66 after Q2 2026 results. Revenue increased to $238.09 million from $189.98 million, but net income fell to a $25.20 million loss from a $65.54 million profit. Normalized FFO was $0.38 and adjusted FFO $0.40, supporting a $0.30 dividend. The company recorded a $102.4 million loan loss provision.
5 min readSabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2026 RESULTS; REITERATES 2026 GUIDANCE TUSTIN, CA, August 3, 2026 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 202
6 min readThe article highlights four high-yield stocks and one mortgage REIT, focusing on dividend yield, volatility (beta), and recent actions. First Interstate BancSystem (FIBK) announced a $150M buyback, totaling $450M, after repurchasing about 8%. Sabra (SBRA) raised full-year FFO/AFFO guidance after a tenant transition with ~30% higher rent. Getty Realty (GTY) and Kinetik (KNTK) are discussed, and Ellington Financial (EFC) is noted for an 11.5% yield with adjusted distributable earnings guidance of
7 min readSabra Health Care REIT (SBRA) shares rose over 10% after the company issued an operational update. Sabra said it signed letters of intent to retenant 26 Avamere properties, targeting $53M annual rent versus $41M prior. It also arranged to retire a $300M RCA mortgage with $200M cash. Sabra raised 2026 guidance to $0.37-$0.39 headline net income and $1.59-$1.61 normalized AFFO.
5 min readAvamere plans to exit skilled nursing by ending management agreements for 26 Sabra Healthcare REIT (SBRA) properties. Sabra will reassign 22 sites to Cascadia Healthcare and four to subsidiaries of an existing tenant. Sabra set Cascadia’s closing rent at $53 million, with the deal expected to close this year, according to Sabra.
5 min readFitch Ratings said four senior housing REITs, CareTrust (CTRE), National Health Investors (NHI), Sabra (SBRA) and Omega (OHI), earned similar “BBB-” credit ratings. Fitch cited differences in liquidity and leverage, noting a trend to reduce skilled nursing exposure and expand managed operating platforms, including RIDEA structures. It also highlighted U.K. exposure and NHI’s positive outlook factor.
7 min readThe article compares senior housing REITs Sabra Health Care (SBRA) and Welltower (WELL), citing improving demand and occupancy. Sabra reported Q1 revenue of $221.7M (+20.8%) and NFFO/share of $0.38 (+8.5%), with 14.4% YoY same-store cash NOI growth. Welltower reported Q1 revenue of $2.78B (+49.1%) and NFFO/share of $1.47 (+22.5%), with NOI up 16.4% YoY.
7 min readSabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. sbra-20260617 false 0001492298 0001492298 2026-06-17 2026-06-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):
2 min read
